Literature DB >> 924683

Granuloma formation in lungs of mice after intravenous administration of emulsified trehalose-6,6'-dimycolate (cord factor): reaction intensity depends on size distribution of the oil droplets.

E Yarkoni, H J Rapp.   

Abstract

The intensity of the granulomatous reaction evoked in lungs of mice by trehalose-6,6'-dimycolate administered intravenously in oil-water emulsion depended on the size distribution of the oil droplets. Emulsions containing the greatest number of the largest oil droplets were the most granulomagenic.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 924683      PMCID： PMC421268          DOI： 10.1128/iai.18.2.552-554.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  20 in total

1.  Histopathology of tumor regression after intralesional injection of Mycobacterium bovis., 2. Comparative effects of vaccinia virus, oxazolone, and turpentine.

Authors:  M G Hanna; B Zbar; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1972-06       Impact factor: 13.506

2.  Adjuvant effect of cord factor, a mycobacterial lipid.

Authors:  R Saito; A Tanaka; K Sugiyama; I Azuma; Y Yamamura
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

3.  Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin.

Authors:  T J Meyer; E Ribi; I Azuma
Journal:  Cell Immunol       Date:  1975-03       Impact factor: 4.868

4.  Immune response to sheep red blood cells in mice pretreated with mycobacterial fractions.

Authors:  A Bekierkunst; E Yarkoni; I Flechner; S Morecki; E Vilkas; E Lederer
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

5.  Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6'-dimycolate).

Authors:  A Bekierkunst
Journal:  Int J Cancer       Date:  1975-09-15       Impact factor: 7.396

6.  Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration.

Authors:  E Yarkoni; M S Meltzer; H J Rapp
Journal:  Int J Cancer       Date:  1977-06-15       Impact factor: 7.396

7.  Granulomatous hypersensitivity to trehalose-6,6'-dimycolate (cord factor) in mice infected with BCG.

Authors:  A Bekierkunst; E Yarkoni
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

8.  Suppression of urethan-induced lung adenomas in mice treated with trehalose-6,6-dimycolate (cord factor) and living bacillus Calmette Guérin.

Authors:  A Bekierkunst; I S Levij; E Yarkoni
Journal:  Science       Date:  1971-12-17       Impact factor: 47.728

9.  Stimulation of macrophages by cord factor and by heat-killed and living BCG.

Authors:  E Yarkoni; L Wang; A Bekierkunst
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Granuloma formation induced in mice by chemically defined mycobacterial fractions.

Authors:  A Bekierkunst; I S Levij; E Yarkoni; E Vilkas; A Adam; E Lederer
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490
View more
  16 in total

1.  Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces corneal angiogenesis in rats.

Authors:  N Saita; N Fujiwara; I Yano; K Soejima; K Kobayashi
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Mycobacterial glycolipid cord factor trehalose 6,6'-dimycolate causes a decrease in serum cortisol during the granulomatous response.

Authors:  Jeffrey K Actor; Jessica Indrigo; Christopher M Beachdel; Margaret Olsen; Alice Wells; Robert L Hunter; Amitava Dasgupta
Journal:  Neuroimmunomodulation       Date:  2002 -2003       Impact factor: 2.492

3.  Influence of oil and Tween concentrations on enhanced endotoxin lethality in mice pretreated with emulsified trehalose-6,6'-dimycolate (cord factor).

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

4.  Regression of a murine fibrosarcoma after intralesional injection of a synthetic C39 glycolipid related to cord factor.

Authors:  E Yarkoni; H J Rapp; J Polonsky; J Varenne; E Lederer
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

5.  Toxicity of emulsified trehalose-6,6'-dimycolate (cord factor) in mice depends on size distribution of mineral oil droplets.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

6.  Regression of a transplanted guinea pig hepatoma after intralesional injection of an emulsified mixture of endotoxin and mycobacterial sulfolipid.

Authors:  E Yarkoni; M B Goren; H J Rapp
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

7.  Interstitial and hemorrhagic pneumonitis induced by mycobacterial trehalose dimycolate.

Authors:  J Seggev; M B Goren; R I Carr; C H Kirkpatrick
Journal:  Am J Pathol       Date:  1982-03       Impact factor: 4.307

8.  Increased synthesis of anti-tuberculous glycolipid immunoglobulin G (IgG) and IgA with cavity formation in patients with pulmonary tuberculosis.

Authors:  Masako Mizusawa; Mizuoho Kawamura; Mikio Takamori; Tetsuya Kashiyama; Akira Fujita; Motoki Usuzawa; Hiroki Saitoh; Yugo Ashino; Ikuya Yano; Toshio Hattori
Journal:  Clin Vaccine Immunol       Date:  2008-01-09

9.  Macrophage activation and resistance to pulmonary tuberculosis.

Authors:  M J Lefford
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

10.  Sensing of mycobacterial arabinogalactan by galectin-9 exacerbates mycobacterial infection.

Authors:  Xiangyang Wu; Yong Wu; Ruijuan Zheng; Fen Tang; Lianhua Qin; Detian Lai; Lu Zhang; Lingming Chen; Bo Yan; Hua Yang; Yang Wang; Feifei Li; Jinyu Zhang; Fei Wang; Lin Wang; Yajuan Cao; Mingtong Ma; Zhonghua Liu; Jianxia Chen; Xiaochen Huang; Jie Wang; Ruiliang Jin; Peng Wang; Qin Sun; Wei Sha; Liangdong Lyu; Pedro Moura-Alves; Anca Dorhoi; Gang Pei; Peng Zhang; Jiayu Chen; Shaorong Gao; Felix Randow; Gucheng Zeng; Chang Chen; Xin-Shan Ye; Stefan H E Kaufmann; Haipeng Liu; Baoxue Ge
Journal:  EMBO Rep       Date:  2021-05-13       Impact factor: 8.807
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.